Already a premier event in just its second year, the annual Boston Biotech Investor Day (BBID) brings together primary biotechnology funders and the scientists and entrepreneurs developing the next generation of breakthroughs. As part of this year’s invitation-only event, a panel of experts including Aitia CEO Colin Hill, Laura Tadvalkar from RA Capital, Paul Fonteyne from Canaan, and Leslie J Williams from HC Bioscience will discuss “Negotiating from Both Sides of the Table,” moderated by Catharine Smith of the Termeer Institute. Other activities during the September 18, 2025 meeting include a keynote presentation from Paula Soteropoulos, Chairman of the Board of Ensoma, and pitches and/or poster presentations from 48 emerging companies to more than 90 investors.
BBID is sponsored by LabCentral, BioLabs and The Engine.